Combination Therapy Using Cellcept and Rebif in RRMS

NCT00618527 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: mycophenolate mofetil (Cellcept)
DRUG: human interferon beta 1a (Rebif)

Sponsor

Aaron Boster

Collaborators

[object Object]
[object Object]